dihydroergotamine has been researched along with alprenolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Ashkenazi, A; Havlik, S; Jin, H; Marsters, SA; O'Dowd, BF; Oksenberg, D; Peroutka, SJ | 1 |
2 other study(ies) available for dihydroergotamine and alprenolol
| Article | Year |
|---|---|
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.
Topics: Alprenolol; Amino Acid Sequence; Animals; Base Sequence; Dihydroergotamine; Humans; In Vitro Techniques; Methiothepin; Methysergide; Mice; Molecular Sequence Data; Pindolol; Propranolol; Rats; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1992 |